Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pdgfra-Associated Chronic Eosinophilic Leukemia × Amplified Fragment Length Polymorphism Analysis × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 6 Lymphoma, Follicular 4 Lymphoma 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Burkitt Lymphoma 3 Waldenstrom Macroglobulinemia 2 Sezary Syndrome 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Accelerated Phase 2 Immunoblastic Lymphadenopathy 2 Congenital Abnormalities 2 Breast Neoplasms 2 Thrombocytopenia 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1

Interventions

fludarabine phosphate 9 Whole-Body Irradiation 7 Peripheral Blood Stem Cell Transplantation 7 Cyclophosphamide 7 Busulfan 7 Mycophenolic Acid 6 Antilymphocyte Serum 6 Tacrolimus 5 Methotrexate 5 Cyclosporine 5 Melphalan 4 Etoposide 4 thymoglobulin 3 Sirolimus 3 Rituximab 3 Cord Blood Stem Cell Transplantation 3 Radiotherapy 2 Ondansetron 2 Granulocyte Colony-Stimulating Factor 2 Dexamethasone 2 Cytarabine 2 Cyclosporins 2 Carmustine 2 Calcium Dobesilate 2 Aprepitant 2 rasburicase 1 fludarabine 1 etoposide phosphate 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡